CYduct Diagnostics, Inc. (CYDX)
Market Cap | 1.06M |
Revenue (ttm) | 344.78K |
Net Income (ttm) | 136.51K |
Shares Out | 5.24M |
EPS (ttm) | n/a |
PE Ratio | 7.80 |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 172 |
Average Volume | 344 |
Open | 0.2031 |
Previous Close | 0.2021 |
Day's Range | 0.2031 - 0.2031 |
52-Week Range | 0.1270 - 0.5320 |
Beta | -1.48 |
RSI | 46.18 |
Earnings Date | n/a |
About CYduct Diagnostics
CYduct Diagnostics, Inc., a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions. The company’s products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber o... [Read more]
Financial Performance
In 2011, CYduct Diagnostics's revenue was $328,612, a decrease of -23.48% compared to the previous year's $429,473. Losses were -$503,787, -57.75% less than in 2010.
Financial StatementsNews

Groundbreaking Study on Risk Assessment of Breast Cancer Aims to Revolutionize Diagnosis and Treatment
WESTPORT, CT / ACCESS Newswire / April 9, 2025 / CYduct Diagnostics, Inc. (OTCPK:CYDX) ("CYduct", or the "Company"), a precision medicine-based women's health company focused on the development of bre...

Cyduct Diagnostics To Participate at the 10th Annual Yale Innovation Summit
Yale Innovation Summit, May 29-30, New Haven, CT. WESTPORT, CT / ACCESSWIRE / May 16, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", "CYductDX", or the "Company"), an innovator in precisio...

CYduct Diagnostics Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer
WESTPORT, CT / ACCESSWIRE / April 2, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", or the "Company"), a precision medicine-based women's health company focused on the development of breas...

CYduct Diagnostics Proudly Supports the "Find It Early Act" to Advance Women's Health
WESTPORT, CT / ACCESSWIRE / October 31, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), CYduct Diagnostics Inc., a leading medical device company committed to revolutioniz...

CYduct Diagnostics Inc. Advocates for Breast Cancer Awareness Month: Pioneering Innovation and Early Detection
WESTPORT, CT / ACCESSWIRE / October 19, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), CYduct Diagnostics Inc., a leading medical device company committed to revolutioniz...

Cyduct Diagnostics Recognizes a Visionary Leader in Breast Health: Dr. Susan Love
WESTPORT, CT / ACCESSWIRE / August 1, 2023 / CYduct Diagnostics, Inc. (OTCPK:CYDX) ("CYduct" or the "Company"), - CYduct Diagnostics an emerging force in women's breast health would like to recognize ...

CYduct Diagnostics Sponsors the Dr. Susan Love Foundation for Breast Cancer Research's 15th Annual Walk With Love
WESTPORT, CT / ACCESSWIRE / June 28, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company") - CYduct Diagnostics, a leading provider of innovative diagnostic solutions, is proud t...

Cyduct Diagnostics Inc. Proudly Sponsors Camp Breastie 2023
WESTPORT, CT / ACCESSWIRE / June 8, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), a company focused on developing life-enhancing breast healthcare products is delighted ...

CYduct Diagnostics Recognized as April's "Innovator of the Month" by U.S. Senator Chris Murphy
WESTPORT, CT / ACCESSWIRE / May 4, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), a company focused on developing life-enhancing breast healthcare products was recently r...

CYduct Diagnostics Inc. Clinical Team Wins Grant and Takes the Stage at the Dr. Susan Love Foundation's 11th International Symposium on the Human Breast
WESTPORT, CT / ACCESSWIRE / February 22, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), is a company focused on developing life-enhancing breast healthcare products, rece...

CYduct Diagnostics Inc. Provides a Corporate Outlook for 2023
WESTPORT, CT / ACCESSWIRE / January 19, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), is a company focused on developing life-enhancing breast healthcare products, and t...

CYduct Diagnostics Inc. Completes Audit of its Consolidated Financial Statements
WESTPORT, CT / ACCESSWIRE / October 4, 2022 / CYduct Diagnostics, Inc. (OTC PINK:CYDX), a medical device company pursuing innovations within the women's healthcare market, primarily breast healthcare ...

CYduct Diagnostics, Inc. Issues Annual Shareholder Update and Letter from the President
WESTPORT, CT / ACCESSWIRE / August 18, 2022 / CYduct Diagnostics, Inc. (OTC PINKK:CYDX), a medical device company pursuing innovations within the women's healthcare market, primarily breast healthcare...

CYduct Diagnostics, Inc. Joins Connecticut's Biosciences Community
WESTPORT, CT / ACCESSWIRE / May 9, 2022 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct") is pleased to announce it has joined BioCT, Connecticut's Biosciences Community. Commenting on CYduct's me...

CYduct Diagnostics, Inc. Announces Year-End Financial Results for Fiscal 2021
WESTPORT, CT / ACCESSWIRE / September 30, 2021 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct") yesterday filed with OTC Markets its financial results for the fiscal years-ended June 30, 2021 and...

Cyduct Diagnostics Inc. Retains TPS Thayer, a PCAOB Registered Certified Public Accounting Firm
WESTPORT, CT / ACCESSWIRE / June 24, 2021 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct") is pleased to announce today that the company has retained the public accounting firm TPS Thayer, LLC. T...

CYduct Diagnostics, Inc. Announces OTC Ticker Symbol Change to "CYDX"
WESTPORT, CT / ACCESSWIRE / December 29, 2020 / CYduct Diagnostics, Inc. (OTC PINK:SNDYD) is pleased to announce that FINRA has approved a change in the Company's stock symbol trading on the OTC Marke...